The Sepsis ImmunoScore™ is the first-ever AI Sepsis Diagnostic granted marketing authorization by the FDA. CHICAGO, April 3, 2024 /PRNewswire/ -- Prenosis, Inc., an artificial intelligence company ...

Overuse of antibiotics early in life may increase the risk for bronchopulmonary dysplasia (BPD) or mortality in very premature infants, a national cohort study from China found. Among 6,510 such ...

Please provide your email address to receive an email when new articles are posted on . Researchers identified five proteins in umbilical cord blood that could signal early-onset sepsis in preterm ...

Artificial intelligence (AI)-driven virtual simulation and training have emerged as game-changers in medical education. Now, a London-based company has launched training modules that use AI and ...

Sepsis is a life-threatening condition caused by organ dysfunction resulting from the body's dysregulated response to infection. Annually, sepsis affects more than 31 million people worldwide, with a ...

Sepsis is a deadly reaction to infection, one that can cause runaway inflammation and a cascade of organ damage. It is estimated to kill at least 350,000 Americans per year. Early detection of this ...

While much of the public conversation around the rise of artificial intelligence has centered on its potential harms, academic and health care researchers have been quietly but aggressively finding ...

A pioneering study presented today at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient ...

Study reveals how Cytovale's IntelliSep® sepsis test enables early sepsis risk stratification and more precise documentation, increasing SEP-1 compliance by 29% SAN FRANCISCO and SALT LAKE CITY, Sept.